Ireland batter Rebecca Stokell accepts voluntary suspension for anti-doping breach
The player admitted to an unintentional violation regarding the reporting of prescription medication following an in-competition test.
Ireland women's batter Rebecca Stokell has entered a voluntary suspension after admitting to an anti-doping rule violation, according to The Hawk.
The breach involved reporting requirements related to the use of prescription medication. Stokell's sample was collected during an in-competition test on June 23, 2026.
Stokell, who has played 29 ODIs and 80 T20Is, stated she accepts responsibility for the error. She noted the substance used was not for performance enhancement.
The International Cricket Council (ICC) said the sample returned an adverse finding for a Specified Substance. The suspension has been in effect since October 23, 2026.
Cricket Ireland director of high performance Graeme West said the organisation is supporting the player but noted the incident serves as a reminder for all international players to follow rules.
The ICC will decide on any final sanctions once the disciplinary process is complete.